These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6321913)

  • 1. Effect of membrane fluidizers on the number and affinity of chemotactic factor receptors on human polymorphonuclear leukocytes.
    Tomonaga A; Hirota M; Snyderman R
    Microbiol Immunol; 1983; 27(11):961-72. PubMed ID: 6321913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoattractant receptor functions in human polymorphonuclear leukocytes are divergently altered by membrane fluidizers.
    Yuli I; Tomonaga A; Synderman R
    Proc Natl Acad Sci U S A; 1982 Oct; 79(19):5906-10. PubMed ID: 6310554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic manipulation of leukocyte chemotaxis. Present knowledge and future trends.
    Snyderman R
    Am J Med; 1983 Oct; 75(4B):10-8. PubMed ID: 6314812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoattractant receptor affinity reflects its ability to transduce different biological responses.
    Snyderman R
    Agents Actions Suppl; 1983; 12():323-36. PubMed ID: 6301234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphotericin B alters the affinity and functional activity of the oligopeptide chemotactic factor receptor on human polymorphonuclear leukocytes.
    Lohr KM; Snyderman R
    J Immunol; 1982 Oct; 129(4):1594-9. PubMed ID: 6286769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deactivation of human neutrophil chemotaxis by chemoattractants: effect on receptors for the chemotactic factor f-Met-Leu-Phe.
    Donabedian H; Gallin JI
    J Immunol; 1981 Sep; 127(3):839-44. PubMed ID: 6790618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transductional mechanisms of chemoattractant receptors on leukocytes.
    Snyderman R; Pike MC
    Contemp Top Immunobiol; 1984; 14():1-28. PubMed ID: 6088171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes.
    Williams LT; Snyderman R; Pike MC; Lefkowitz RJ
    Proc Natl Acad Sci U S A; 1977 Mar; 74(3):1204-8. PubMed ID: 265563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the formyl peptide chemotactic receptor appearing at the phagocytic cell surface after exposure to phorbol myristate acetate.
    Gardner JP; Melnick DA; Malech HL
    J Immunol; 1986 Feb; 136(4):1400-5. PubMed ID: 3511145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The formylpeptide chemotactic receptor on rabbit peritoneal neutrophils. I. Evidence for two binding sites with different affinities.
    Mackin WM; Huang CK; Becker EL
    J Immunol; 1982 Oct; 129(4):1608-11. PubMed ID: 6286772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of indomethacin on the binding of the chemotactic peptide formyl-Met-Leu-Phe on human polymorphonuclear leukocytes.
    Cost H; Gespach C; Abita JP
    FEBS Lett; 1981 Sep; 132(1):85-8. PubMed ID: 6271584
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulatory mechanisms of a chemoattractant receptor on leukocytes.
    Snyderman R
    Fed Proc; 1984 Sep; 43(12):2743-8. PubMed ID: 6088298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal membrane fluidity as a cause of impaired functional dynamics of chemoattractant receptors on neonatal polymorphonuclear leukocytes: lack of modulation of the receptors by a membrane fluidizer.
    Yasui K; Masuda M; Matsuoka T; Yamazaki M; Komiyama A; Akabane T; Hasui M; Kobayashi Y; Murata K
    Pediatr Res; 1988 Oct; 24(4):442-6. PubMed ID: 2845343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoattractants induce rapid release of the interleukin 1 type II decoy receptor in human polymorphonuclear cells.
    Colotta F; Orlando S; Fadlon EJ; Sozzani S; Matteucci C; Mantovani A
    J Exp Med; 1995 Jun; 181(6):2181-6. PubMed ID: 7760005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formyl peptide leukocyte chemoattractant uptake and release by cultured human umbilical vein endothelial cells.
    Rotrosen D; Malech HL; Gallin JI
    J Immunol; 1987 Nov; 139(9):3034-40. PubMed ID: 3668252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory mechanisms of a chemoattractant receptor on human polymorphonuclear leukocytes.
    Snyderman R
    Rev Infect Dis; 1985; 7(3):390-4. PubMed ID: 4023529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laminin promotes the oxidative burst in human neutrophils via increased chemoattractant receptor expression.
    Pike MC; Wicha MS; Yoon P; Mayo L; Boxer LA
    J Immunol; 1989 Mar; 142(6):2004-11. PubMed ID: 2537868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-Formylmethionyl peptide receptors on equine leukocytes initiate secretion but not chemotaxis.
    Snyderman R; Pike MC
    Science; 1980 Jul; 209(4455):493-5. PubMed ID: 6248959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of polymorphonuclear leukocyte chemiluminescent response to the chemoattractant f-Met-Leu-Phe.
    Dahlgren C; Magnusson KE; Stendahl O; Sundqvist T
    Int Arch Allergy Appl Immunol; 1982; 68(1):79-83. PubMed ID: 6281196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chlorpromazine inhibits neutrophil chemotaxis beyond the chemotactic receptor-ligand interaction.
    Lohr KM; Feix JB; Kurth C
    J Infect Dis; 1984 Nov; 150(5):643-52. PubMed ID: 6092486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.